ATLANTA—A component of red wine and grapes can help control inflammation induced by a bacterial pathogen that is linked to upper respiratory tract inflammatory diseases such as asthma, chronic obstructive pulmonary diseases (COPD) and middle ear infection (otitis media), according to a study by researchers at Georgia State University.
ATLANTA—The Georgia State University Research Foundation (GSURF) created a licensing and sponsored research agreement with Aviragen Therapeutics, Inc., to develop the next generation of antivirals commercialize respiratory syncytial virus (RSV) replication inhibitors.
ATLANTA—Andrew Gewirtz, a professor in the Institute for Biomedical Sciences at Georgia State University, has received a four-year, $1.8-million federal grant to study how changes in intestinal bacteria could lead to obesity and metabolic syndrome.
ATLANTA—Edible ginger-derived nano-lipids created from a specific population of ginger nanoparticles show promise for effectively targeting and delivering chemotherapeutic drugs used to treat colon cancer, according to a study by researchers at the Institute for Biomedical Sciences at Georgia State University,
Dr. Jian-Dong Li, director of the Institute for Biomedical Sciences at Georgia State University and a Georgia Research Alliance Eminent Scholar, has been appointed to the National Deafness and Other Communication Disorders Advisory Council.
A novel antiviral drug may protect people infected with the measles from getting sick and prevent them from spreading the virus to others, an international team of researchers says.
ATLANTA – A potential new strategy to developing new drugs to control inflammation without serious side effects has been found by Georgia State University researchers and international colleagues.
ATLANTA – Sang-Moo Kang, associate professor at Georgia State University’s Center for Inflammation, Immunity and Infection, has received a federal five-year, $3.7 million grant to bolster research that will lead to better flu vaccines and vaccines against respiratory syncytial virus (RSV), a disease for which there is no vaccine.
ATLANTA – A new process to make a one-time, universal influenza vaccine has been discovered by a researcher at Georgia State University’s Center for Inflammation, Immunity and Infection and his partners.
ATLANTA – Results from a study conducted at Georgia State University suggest that a “fight” between bacteria normally living in the intestines and the immune system, kicked off by another type of bacteria, may be linked to two types of chronic disease.
